Clinical Trials & Research

The Role of PARP Inhibitors in Prostate Cancer Management

February 10th, 2026 | Clinical Trials & Research

What Are PARP Inhibitors? PARP inhibitors (often called PARPi) are cancer medicines you take as pills. PARP is a protein your cells use to fix small breaks in their DNA. PARP inhibitors block this repair process. When cancer cells can’t fix their DNA damage, they may stop growing or die. PARP inhibitors studied and used […]

T-Cell Engager Therapy for Prostate Cancer: An Easy-to-Understand Guide

January 27th, 2026 | Clinical Trials & Research

Prostate cancer is often treatable. Many people do well with surgery, radiation, or hormone therapy. However, sometimes the cancer comes back. Sometimes it spreads to other parts of the body. When that happens, doctors and researchers look for new options. One option being studied is a T-cell engager therapy. It is a type of immunotherapy that […]

The MEVPRO Clinical Trials: What You Need to Know

March 12th, 2025 | Clinical Trials & Research

AUA’s Urology Practice Publishes PHEN’s Peer-Reviewed Study: Black Men Not Being Asked to Participate in Prostate Cancer Clinical Trials

January 22nd, 2025 | Clinical Trials & Research

Managing Survivorship Meeting: The Find Your Trial (FYT) Tool Increases Access to Prostate Cancer Clinical Trials

December 19th, 2024 | Clinical Trials & Research

PHEN Expands Access for Prostate Cancer Patients to Find Clinical Trials Near Them with New “Find Your Trial” (FYT) Tool

December 11th, 2024 | Clinical Trials & Research

Congratulations to our Dr. Crawford whose article “Narrowing the Diversity Gap” in Clinical Trials launched today in USA Today and on Future of Personal Health!

September 13th, 2024 | Clinical Trials & Research

 

PHEN Survivor Network Member Art Cain Beats Prostate Cancer with PANTHER Trial After Attending PHEN Summit

July 22nd, 2024 | Clinical Trials & Research

Black men are 70% more likely to become diagnosed with prostate cancer as all other men and more than twice as likely to die from this disease. However, diverse patient enrollment in prostate cancer clinical trials may make a difference in reducing this racial disparity. PHEN Survivor Network Member Art Cain is one such man […]

How PHEN’s Clinical Trials Navigation Hotline Can Help You

April 2nd, 2024 | Clinical Trials & Research

How can clinical researchers and pharmaceutical companies increase the diversity of their clinical trial subjects?

December 21st, 2023 | Clinical Trials & Research

Pin It on Pinterest